Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Assets (Quarterly) : 1.428B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.428B |
| March 31, 2026 | 1.501B |
| December 31, 2025 | 1.614B |
| September 30, 2025 | 1.420B |
| June 30, 2025 | 1.382B |
| March 31, 2025 | 1.347B |
| December 31, 2024 | 1.501B |
| September 30, 2024 | 1.343B |
| June 30, 2024 | 1.316B |
| March 31, 2024 | 1.304B |
| December 31, 2023 | 1.409B |
| September 30, 2023 | 1.285B |
| June 30, 2023 | 1.293B |
| March 31, 2023 | 1.792B |
| December 31, 2022 | 1.837B |
| September 30, 2022 | 1.693B |
| June 30, 2022 | 1.695B |
| March 31, 2022 | 1.640B |
| December 31, 2021 | 1.833B |
| September 30, 2021 | 1.555B |
| June 30, 2021 | 1.573B |
| March 31, 2021 | 1.507B |
| December 31, 2020 | 1.587B |
| September 30, 2020 | 1.510B |
| June 30, 2020 | 1.491B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.190B |
| December 31, 2019 | 1.198B |
| September 30, 2019 | 1.107B |
| June 30, 2019 | 1.064B |
| March 31, 2019 | 1.025B |
| December 31, 2018 | 1.009B |
| September 30, 2018 | 922.51M |
| June 30, 2018 | 852.80M |
| March 31, 2018 | 825.16M |
| December 31, 2017 | 439.43M |
| September 30, 2017 | 385.48M |
| June 30, 2017 | 346.37M |
| March 31, 2017 | 322.26M |
| December 31, 2016 | 309.57M |
| September 30, 2016 | 285.12M |
| June 30, 2016 | 218.63M |
| March 31, 2016 | 194.47M |
| December 31, 2015 | 188.63M |
| September 30, 2015 | 166.77M |
| June 30, 2015 | 154.01M |
| March 31, 2015 | 139.40M |
| December 31, 2014 | 137.51M |
| September 30, 2014 | 126.32M |
| June 30, 2014 | 94.19M |
| March 31, 2014 | 97.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 1.233B |
| Pfizer Inc. | 201.13B |
| Amphastar Pharmaceuticals, Inc. | 1.744B |
| Collegium Pharmaceutical, Inc. | 2.136B |
| Bristol Myers Squibb Co. | 87.63B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 396.88M |
| Shareholders Equity (Quarterly) | 1.031B |
| Debt to Equity Ratio | 0.039 |
| Current Ratio | 2.083 |
| Net Debt Paydown Yield | -0.06% |